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THE pathogenic action of most mouse leukaemia viruses is difficult to study
on account of the long and variable time before the appearance of leukaemia.
Useful information on the multiplication and pathogenesis of these viruses might
be obtained if a virus could be found which modifies their pathogenicity or,
alternatively, which has its own pathogenicity modified. Mouse hepatitis virus
(MHV1) seemed a suitable choice for such an investigation: its pathogenic action
is stable and predictable; it produces mild hepatitis in normal weanling mice and
fatal hepatitis in weanling mice recently infected with Eperythrozoon coccoides
(Niven, Gledhill, Dick and Andrews, 1952); and, it bears a general resemblance
to many leukaemia viruses, e.g. in size, thermolability, host specificity (cf. Gledhill,
Dick and Niven, 1955, and Moloney, 1960b). Experiments described here were
undertaken to study dual infections of mice with MHV1 and Friend or Molonev
leukaemia agents (Friend, 1957; Moloney, 1960a). It was found that, while prior
inoculation of MHV1 reduced the pathogenicity of Friend leukaemia agent, fatal
hepatitis resulted if the hepatitis virus was inoculated several days after the
Friend agent. The latter phenomenon closely resembled the enhancement of
MHV1 by E. coccoides. The Moloney leukaemia agent also enhanced MHV1
provided the inoculation preceded that of MHV1 by at least 20 days but the
enhancement was somewhat less marked. The enhancement may provide a
useful method for titration of Moloney agent.
MATERIALS AND METHODS
Mice
Two strains of white mice, designated " Albany " and " Swiss ", were used.
Both had been bred for many years at the farm of the Division of Laboratories
and Research, New York State Department of Health, Albany. In some experi-
ments 1-2 day old mice were employed; these are termed " baby " mice. In
other experiments newly weaned mice aged 20-28 days (8-12 g.) were used;
these are termed " weanling " mice. Albany mice were used for experiments to
show enhancement of MHV1 because they appeared more susceptible to MHV1
than Swiss mice. Swiss mice were employed to demonstrate Moloney leukaemia
because limited experience suggested that theydevelop it sooner than Albanymice.
Inoculations
In all experiments described the route of inoculation was intraperitoneal and
the inoculum was 0*2 ml. for weanling mice and 0 03 ml. for unweaned mice.
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The diluent of all tissue suspensions for inoculation or storage was a mixture of
equal parts 0-85 per cent saline and 10 per cent horse serum broth, referred to as
SS broth.
Preparation of virus suspensions
The Friend and Moloney leukaemia agents were obtained as lyophilised tissue
suspensions from Dr. Charlotte Friend and Dr. J. B. Moloney. The reconstituted
Friend agent was inoculated into Swiss weanlings and passed as a 1 per cent
spleen suspension on the 27th day into similar mice. On the 13th day spleen
suspension from these mice was passed into Albany weanlings which were killed
after 14 days. The supernatant of a centrifuged 10 per cent suspension of their
spleens was distributed in small bottles and stored at 80° as a pool for use in
experiments.
The reconstituted Moloney agent was inoculated into and passed in baby
Swiss mice. In the third pass using lymph node suspensions, a mouse developed
leukaemia in 86 days. The supernatant of (1) the centrifuged spleen suspension
(MI/S) and (2) the centrifuged lymph node suspension (M1/L) from this mouse
were stored separately at -800. Reconstituted suspension from another original
ampoule was inoculated into baby Swiss mice. Some of these were sacrificed after
12 days and liver-spleen suspension inoculated into similar mice. One of these
developed leukaemia in 60 days and the supernatant after 3 cycles of centrifuga-
tion of a suspension of lymph nodes and thymus (M2/T) was employed in one
experiment. Others of the mice inoculated from the second original ampoule
were sacrificed at 27 days and a suspension of spleens and lymph nodes was
inoculated into baby Swiss mice. One with signs of leukaemia was killed on the
76th day. A lymph node suspension from this mouse was frozen and slowly thawed
three times and then centrifuged. The supernatant (M2/L) was stored at -80°
for use in another experiment.
Lyophilised liver-spleen suspension of MHV1 was inoculated into weanling
Albany mice. A liver-spleen suspension of these was passed into weanling Albany
mice which were killed on the 5th day. The supernatant of a centrifuged 10 per
cent liver-spleen suspension from these mice was distributed in bottles and
stored at 800. In the experiments to be described mice were inoculated with
a 1 : 10 dilution of the stored suspension. Titration of the stored suspension in
Albany mice treated two days previously with E. coccoides showed that 0-2 ml.
ofa 1 per cent suspension contained about 100 LD50. In the absence ofE. coccoides
such an inoculum produced mild non-lethal hepatitis in weanling Albany mice.
Assessment of hepatitis and method of titration ofpotentiating agents
Weanling mice inoculated with MHV1 in the above dose were killed oIn the
6th day (unless otherwise stated). The surfaces of the liver were examined both
before and after they had been bled by severance of the aorta. The liver lesions
were recorded in the following way:
Appearance of liver Score
No obvious focal lesions 0
A few focal lesions .
Many focal lesions . . 2
Coalescence of focal lesions to give generalised liver abnormality . 3
Liver bright yellow background with haemorrhagic areas . 4
Mouse dead with liver appearance as in the last group 5
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Weanling Albany mice inoculated only with MHVl scored mostlv 1, with 0
and 2 scored quite often. About 1 in 20 scored 3 and none scored 4 or 5 during
these experiments. In mice inoculated with an agent able to potentiate MHV1,
mice which scored 3, 4 or 5 were regarded as infected with the potentiating agent.
Thus, when E. coccoides was used to potentiate MHV1 in Albanv mice, more
than half were dead by the 6th day after the vTirus inoculation and the remainder
scored 3 and 4.
The method adopted for the indirect titration ofagents which potentiate MHr1
was intraperitoneal inoculation of decimal dilutions of the agent in SS broth into
groups of mice in the usual doses. This was followed by the intraperitoneal
inoculation of MHV71 in the usual dose. The age of mice used for inoculation of
the potentiating agent was selected so that the potentiation would be maximal
when they reached 20-28 days, the age at which MHV1 was inoculated. Weanling
mice satisfied this condition for Friend agent and baby mice for Moloney agent.
A group inoculated with MHVl without any potentiating agent was also included.
As indicated above, any mice which scored more than 2 were regarded as infected
with the potentiating agent and the ID50 was calculated from the proportion in-
fected at each dilution bv the method of Reed and Muench (1938).
For direct titrations, groups ofmice were inoculated with dilutions ofleukaemia
agent, as with indirect titrations. With Friend agent they were killed after 14
days and infected mice then showed obvious splenomegaly. For precision each
spleen heavier than 0-2 g. was considered infected. This weight was rather more
than double that of the average normal spleen which was 0 09 g. In fact, most
infected spleens were much heavier than 0-2 g (mean about 0-9 g.). With Moloney
agent, mice were examined daily. Any which developed easily palpable lymph
nodes were killed and the diagnosis based on the gross lesions. To terminate an
-experiment all survivors were killed and diagnosis of leukaemia was again based
on lesions seen at autopsy. The ID50 was calculated, as in the indirect titration,
-from the proportion of infected mice in each diltution.
RESULTS
Experiments with Friend agent and MHVI
In a preliminary experiment, MHV1 was inoculated into groups of 10 weanling
Swiss mice 7, 4 and 1 days before and 2 and 6 days after inoculation of 1 per cent
spleen suspension containing Friend agent. The mice were killed 14 days after
inoculation of the Friend agent and spleen of each was weighed. The experiment
was repeated with weanling mice of the Albany strain and the results of both
*experiments are shown in Table I. The most remarkable and unexpected ob-
servation was the high mortality from hepatitis in the Albany mice inoculated
with MHV1 six days after Friend agent. Although only one Swiss mouse of the
corresponding group died, the degree of hepatitis manifested at autopsy was
greater than that produced by MHV1 in normal Swiss mice. As will be seen, the
mean spleen weights of both strains of mice inoculated with MHV1 7 and 4 days
before and 6 days after Friend agent are below those of the groups which received
Friend agent only and, except for the Albany group which received MHV1 7 days
before Friend agent, the differences are in fact significant at the 0-02 level of
-probability. In contrast, the mean spleen weights of mice inoculated with MHV1
*one day before and 2 davs after Friend agent are not below those of the groups
0533A. W. GLEDHILL
TABLE I. The Effect of Dual Infection with MHV1 and Friend Agent in Swiss and
Albany Weanlings
Swiss mice Albanymice
~-
Time of inoculation Mortality from Average Mortality from Average
MHV1 in relation to acute hepatitis spleen weight acute hepatitis spleen weight
Friend inoculation Mice which died of survivors Mice which died of survivors
(days) Miee in groupi) (g.) Miee in group (g.)
-7 0/10 047 . 0/10 073
-4 . 0/1 057 0/10 0 59
-1 1/10 1*07 . 0/10 1*25
+2 0/10 1*15 . 1/10 083
+6 1/10 042 7/10 (027)*
FriendagQntonly . (/10 092 0/19 097
Ulninoculated . .. .. 0/10 012
Mice killed on the 14th day after inoculation of I per cent suspension of the Frielnd agent anld
s)leens weighed individually.
* Mean based upon only three observations.
given only Friend agent. In another experiment in which groups of 10 Albany
mice were inoculated with MHV1 4, 5, 6, 7 and 8 days after the Friend agent, the
mortalities from acute hepatitis were 5, 5,10,10 and 10. The mean spleen weights
of the 5 survivors in the groups which received MHV1 4 and 5 days after Friend
agent (0.74 and 0-88 g.) were not less than that for the group which received only
Friend agent (0 74 g.). Other experiments have confirmed that when MHV1 is
given between 7 and 4 days before Friend agent, the splenic enlargement due to
the latter is reduced; but the splenic enlargement is not lessened by MHV1 given
in the period from one day before to 5 days after the Friend agent. When MHV'l
is given six days after the Friend agent splenic enlargement is apparently reduced
but the evidence for this is based only on the results depicted in Table I.
The experiments cited, together with others, showed that when the inoculation
into weanling Albany mice of Friend agent precedes that of MHV1 by several days
the pathogenicity of MHV1 is much increased. In the following experiment this
enhancement of pathogenicity was used as an indirect means of titration of the
Friend agent and the result compared with the direct method. The dilutions of
Friend agent were inoculated into groups of 20 mice and each group was split
into equal parts to give two sets of titrations with an uninoculated control group
for each set. Eight days later all mice of one set were inoculated with the usual
dose of MHV1. The hepatitis in those which died and in the survivors killed on
the sixth day was scored as described under Methods. The mice of the duplicate
set were also killed 14 days after inoculation of Friend agent and, as indicated
earlier, each mouse whose spleen was heavier than 0-2 g. was considered to be
positive. The results are shown in Table II. The ID50 by the indirect method
was 10-4.2 g. of spleen and by the direct method 10-5 g. of spleen.
Experiments with Moloney agent and MHV1
Preliminary experiments with Moloney agent showed that it enhanced the-
virulence of MHV1 provided it was inoculated into baby mice 20-28 days before-
the MHV1 inoculation. In one experiment a group of 10 baby mice was inoculated
with suspension of infected Moloney lymph node (Ml/L). One died during lac-
tation. The rest were weaned at 21 days old and given the usual inoculation of
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TABLE II.- Direct and Indirect Titration of Friend Agent
f--
Hepatitis scored
No. mice graded as
0 1 2 3 4 5
6 4 0 0 0 0
5 5 0 0 0 0
6 1 3 0 0 0
3 4 2 1 0 0
4 4 2 0 0 0
4 5 0 1 0 0
2 3 3 1 1 0
0 1 2 1 4 2
0 0 0 1 4 5
0 0 0 0 1 9
fndirect titration
Mortality
Mice which died
Mice in group
0/10
0/10
0/10
0/1)
0/10
0/10
0/10
2/10
5/10
9/10
Indirect titration
Usual dose of MHV I inoculated 8 days aftei Friend agent.
Surviving mice sacrificed on 14th day after Friend inoculation and considered infected with
Friend agent when hepatitis score > 2.
Direct titration
Killed on 14th day after Frienid inoculation and considered infected with Friend agelnt when
.spleen weight > 0 2 g.
MHV1. Six died of acute hepatitis on the 6th and 7th days and the livers of the
remainder killed on the 7th day scored 3, 2 and 1. In another experiment, 8 baby
mice were inoculated with Moloney suspension MI/S followed by MHVI 28 days
later. When killed, all showed severe hepatitis and scored 3 or more.
An attempt was made to titrate Moloney agent by the potentiation of MHV1.
Groups containing 10 or 11 baby mice were inoculated with dilutions of the
M[oloney lymph node preparation M2/L and a group of similar mice received an
-inoculation ofSS broth only. Twenty-six days later, all mice were inoculated with
-the usual dose of MHV1 and after a further six days the degree ofhepatitis scored
in the usiual way. The results, shown in Table III, led to a value of 10-6.4 g. of
TABLE III. Indirect Titration of Moloney Agent M2/L
Dilution of
Moloney agent
M2/L
(-log00)
6
4
3
2
1
Hepatitis scored
No. mice graded as
0 1 2 3 4 5
1 9 1 0 0 0
0 9 1 0 0 0
3 4 0 2 0 1
0 3 2 4 2 0
5 2 3 1 0 0
0 5 0 4 1 0
0 1 1 9 0 0
ID50
Infection rate
Mice infected
Mice in group
0/11
0/10
3/10
6/11
1/11
5/10
9/11
10-6.5 g.
Usual dose of MHV1 inoculated 26 days after dilutions of Moloney agent.
Mice killed on 6th day after MHV1 inoculation and considered infected with Moloney agent when
hepatitis score > 2.
Dilution of
Friend agent
log,10)
9
8
7
6
3
2
1
Infection rate
Mice infected
Mice in group
0/10
0/10
0/10
1/10
0 /10
1/10
2/10
7 /10
10/10
10/10
10-4.2 g. ID50
Direct
titratioin
Infection rate
Mice infected
-Mice in group
0/7
0/10
0/10
0/10
0/10
6/10
6/10
10/10
9/9
10/10
10-5 g.A. W. GLEDHILL
tissue for the ID50. In another indirect titration, groups of baby mice were inocu-
lated with dilutions of Moloney suspension (M2/T). Twenty days later they were
inoculated with MHVI and the degree of hepatitis scored on the 6th day. The
results, verv similar to those of the last experiment, are shown briefly in Table IN'
TABLE IV. Direct and Indirect Titration of Moloney Agent
Indirect Direct titration
J)ilution of titration ,-
Moloney agetnt Mice infected MIice infected Time of recognition of leukaemia Meani
log10) Mice in group* Miee in group* (days from inoculation) (days)
0x . (}/7
7 0/9 0/9
6 1/9 1/7 157 (157)t
.5 . 2/10 2/3 96, 157 (127)t
4 3/10 2/7 122, 146 (134)t
3 7 /8 5 /9 89, 122, 137, 143, 153 129
2 4/10 8/9 104, 122, 122, 122, 150, 153, 1,57, 1.57 136
1 7/10 7/8 94. 96. 104, 104, 122, 122. 157 114
1D50 g. 10-4-6 10-4.9
Indlirect titration
Albany baby mice (1-2 days) inoculated with Moloney suspens-ion M2/T.
Usual dose of MHVl inoculated 20 days after Moloney.
Mice killed on 6th day after MHV1 inoculation and consider-ed infected with Mlolonev agelnt wlielL
hepatitis score >2.
Direct titration
Swiss baby mice (2-4 days) inoculated with Moloney suspension M2 /T.
Mice with signs of leukaemia killed and diagnosis based on gross lesions. Remiiainder sacrificed;
157 days after inoculation and examined for leukaemia.
* At the comtlmencement all groups contained 10 baby mice. The majority of non-speeitic losses.
occurred during lactation.
t Means based on only two or less observations.
and led to an ID50 of 10-4.6 g. of tissue. The experiment took 26 days. In order
to obtain a direct titration, the dilutions of Moloney agent M2/T used in this.
experiment were also inoculated into groups of baby Swiss mice. As indicated
in Methods, diagnosis of leukaemia was based upon lesions in mice killed during
the currency of the experiment and in survivors sacrificed at its termination on
the 157th day. The results, shown in detail in Table IV, led to an ID50 of
10-4 g. of tissue.
DISCUSSION
The enhancement of the pathogenicity of MHV1 by the infectious agent
E. coccoides suggests that the enhancement produced by the tissue preparations.
containing Friend or Moloney leukaemia agents may be due to infectious agents.
This view is supported by the fact that even dilute preparations containing Friend
and Moloney agents enhance MHV1 and by the observation that Moloney agent
must be inoculated as long as 20 or more days before MHV1 to increase its.
pathogenicity. Furthermore, the fact that-for enhancement of MHV1 the times.
of pre-inoculation of preparations containing Friend agent and Moloney agent
are considerably different suggests that different infectious agents are operative
in each case and this indirectly supports the contention that Friend agent and
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Moloney agent themselves are responsible for the enhancement. Nevertheless.
the possibility that the enhancement is due to other factors present in the pre-
parations cannot be excluded until purified preparations of Friend and Moloney
agents are available.
Eperythrozoon coccoides enhances the pathogenicity ofMH\ 1 during the periodl
of high concentration of the parasite in mouse tissues (Gledhill, 1956). If this is
also true for the enhancement of MHV1 by Friend and Molonev agents, it would
imply that Friend agent attains a high titre in 4-7 days and Moloney agent in abouit
3 weeks. The point of interest, especially in the case of the Moloney agent, is that
the virus would be present in high titre long before signs of leukaemia appear.
For example, it might be that a certain cell-virus relationship of infrequent occur-
rence is required to produce the initial leukaemic cell. Indeed, if such were the
case, most well adapted viruses which multiply over long periods of time with
little or no direct pathogenic action might be potential agents of tumour
production.
The capacitv ofMoloney agenit to potentiate MHAV1 is less marked than that of
Friend agent or E. coccoides. Nevertheless it is sufficient to obtain a titration within
a month and, since the time to produce leukaemia is so long and indefinite, this
appears of considerable practical value. It would be interesting to determine
whether other mouse tumour viruses potentiate MHV1.
The smaller amount of splenic enlargement when MHV1 is inoculated about
3-7 days before Friend agent could perhaps be ascribed to some form of viral
interference. The smaller amount of splenic enlargement which probably occurs
when MHV1 is inoculated 6 days after Friend agent is more difficult to explain:
it might be due to the capacity of MHV1 to parasitise and inhibit the division of
tumour cells. Experiments to determine whether MHVI interferes with Moloney
agentin the same way as with Friend agent have not been undertaken. Unlessthe
interference were much stronger than that of MHV1 towards Friend agent, it
would be very difficult to detect since the onset of leuikaemia occuirs at times
scattered over several months.
SUNIMARY
WAhen Friend leukaemia agent was inoculated intraperitoneally into weanling
mice from 4 to at least 8 days before intraperitoneal inoculation ofmouse hepatitis
virus (MHV1), the pathogenicity of the latter virus was much increased.
A similar but somewhat less marked enhancement of the pathogenicity of
MHVI occurred when 1-2 day old mice were inoculated with Moloney leukaemia
agent 20-28 days before they were inoculated with MHV1.
The magnitude ofpotentiation ofMHVI with both Friend and Moloney agents
depended on the strain of mice employed. In both cases it was greater in Albany
than in Swiss mice.
The potentiation ofMHVl by these two agents can provide an indirect method
of titration. With a suspension of Friend agent an ID50 of 10-4.2 g. of spleen was
obtained compared with 10-5-5 g. by a direct method based upon splenic enlarge-
ment. Two different suspensions of Moloney agent yielded ID50s of 10-6.4 and
10-4.6 g. of tissue by the indirect method. The latter suspension titrated by the
direct method gave an ID50 of 10-4.9 g. and took 157 days compared with 26 days
for the indirect titration.
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MHVI given 4-7 days before Friend agent reduced the amount of splenic
enlargement which Friend agent produced in 14 days. MHV1 given 6 days after
Friend agent also reduced the spleen weight but MHV1 given in the period from
about 2 days before to 5 days after the Friend inoculation did not reduce the
amount of splenic enlargement.
This work was supported by a grant from the National Foundation and
Grant No. T-146 from the American Cancer Society. The author wishes to thank
Dr. J. E. Hotchin for the invitation and provision of facilities to work in the virus
department of the Division of Laboratories and Research, New York State
Department of Health, Albany, N.Y.
The competent technical assistance of Miss Ruth Buckley is gratefully
acknowledged.
REFERENCES
FRIEND, CHARLOTTE.-(1957) J. exp. Med., 105, 307.
GLEDHILL, A. W.-(1956) J. gen. Microbiot., 15, 292.
Idem, DICK, G. W. A. AND NIvEN, JANET S. F.-(1955) J. Path. Bact., 69, 299.
MOLONEY, J. B.-(1960a) J. nat. Cancer Inst., 24, 933.-(1960b) Symposium: Pheno-
mena of Tumor Viruses, U.S. Department of Health, Education & Welfare, p. 7.
NIVEN, JANET S. F., GLEDHILL, A. W., DICK, G. W. A. AND ANDREWES, C. H.-(1952)
Lancet, ii, 1061.
REED, L. J. AND MUENCH, H.-(1938) Amer. J. Hyg., 27, 493.